PolyPid Ltd. (PYPD) |
| 5.15 -0.01 (-0.19%) 09-11 16:00 |
| Open: | 5.185 |
| High: | 5.24 |
| Low: | 5.04 |
| Volume: | 99,332 |
| Market Cap: | 98(M) |
| PE Ratio: | -3.48 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 6.48 |
| Resistance 1: | 5.55 |
| Pivot price: | 5.18 |
| Support 1: | 4.93 |
| Support 2: | 4.54 |
| 52w High: | 5.73 |
| 52w Low: | 3.06 |
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
Financials
| EPS | -1.310 |
| Book Value | 0.260 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -74.6 |
| Return on Equity (ttm) | -243.6 |
Company news
Wed, 12 Aug 2026
PolyPid Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Thu, 30 Jul 2026
PolyPid Schedules 8:30 a.m. Webcast for Aug. 12 Results - Stock Titan
Thu, 23 Jul 2026
Antibacterial Drug Partnership Accelerates PolyPid Commercial Path - Streetwise Reports
Wed, 22 Jul 2026
H.C. Wainwright reiterates Buy on PolyPid stock, $13 target - Investing.com
Tue, 21 Jul 2026
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid - Yahoo Finance
Tue, 21 Jul 2026
PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
